Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. (Q48630222)

13 February 2018

title

Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. (English)

1 reference

13 February 2018

0 references

0 references

1

1 reference

13 February 2018

Kaj Blennow

series ordinal

5

object named as

Kaj Blennow

1 reference

PubMed ID

11955966

13 February 2018

Carl-Gerhard Gottfries

series ordinal

3

object named as

Carl-Gerhard Gottfries

1 reference

13 February 2018

Pia Davidsson

2

1 reference

13 February 2018

Jan-Eric Månsson

series ordinal

4

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Schizophrenia Research

1 reference

13 February 2018

volume

55

1 reference

13 February 2018

issue

1-2

1 reference

13 February 2018

page(s)

83-88

1 reference

13 February 2018

Neurobiological investigations in cingulate cortex of schizophrenic brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Synaptic degeneration in thalamus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Recent advances in the neuropathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fat consumption and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Neurochemical dissection of synaptic pathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Defining the course of brain structural change and plasticity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Regional brain volume change over the life-time course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Fatty acids and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Abnormal reinnervation as a basis for schizophrenia: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

A procedure for the quantitative isolation of brain gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900197-9

7 January 2021

10.1016/S0920-9964(01)00197-9

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

11955966

1 reference

13 February 2018